Kazunori Toyoda / MD, PhD, FESO, FAHA
– Deputy Director General of the Hospital and Chair, Department of Stroke and Cerebrovascular Diseases, National Cerebral and Cardiovascular Center (NCVC), Suita, Osaka, Japan
– 1987 MD, Faculty of Medicine, Kyushu University, Fukuoka
– 1994 PhD, Faculty of Medicine, Kyushu University
– The immediate past Board of Directors member of World Stroke Organization (~2024)
– The immediate past Executive Committee member of Asia Pacific Stroke Organization (~2023)
– Board member of the following domestic societies, including Japanese Society of Neurology, Japan Stroke Society, Japanese Society of Hypertension, Japanese Society of Cerebral Blood Flow and Metabolism, and Cardiovascular Stroke Society of Japan
– Congress Chair of THE 10TH KOREA-JAPAN JOINT STROKE CONFERENCE 2022 (KJJSC2022 Osaka)
– Congress Chair of the annual meeting of JAPAN STROKE SOCIETY (STROKE 2025 Osaka): just completed!!
– Co-principal investigator of the Tenecteplase versus alteplase For LArge Vessel Occlusion Recanalization (T-FLAVOR) trial with the ultimate goal of official approval of tenecteplase for acute stroke in Japan
– Second visit to Australia in my lifetime, following APSC 2024 in Adelaide